Sinovac Biotech Ltd. – Product Pipeline Review

Global Markets Direct’s, ‘Sinovac Biotech Ltd. – Product Pipeline Review – 2016’, provides an overview of the Sinovac Biotech Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sinovac Biotech Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Sinovac Biotech Ltd.

The report provides overview of Sinovac Biotech Ltd. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Sinovac Biotech Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Sinovac Biotech Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Sinovac Biotech Ltd.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Sinovac Biotech Ltd.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Sinovac Biotech Ltd.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Sinovac Biotech Ltd. Snapshot 5

Sinovac Biotech Ltd. Overview 5

Key Facts 5

Sinovac Biotech Ltd. - Research and Development Overview 6

Key Therapeutic Areas 6

Sinovac Biotech Ltd. - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Combination Treatment Modalities 11

Pipeline Products - Partnered Products 12

Partnered Products/Combination Treatment Modalities 13

Sinovac Biotech Ltd. - Pipeline Products Glance 14

Sinovac Biotech Ltd. - Clinical Stage Pipeline Products 14

Phase I Products/Combination Treatment Modalities 14

Sinovac Biotech Ltd. - Early Stage Pipeline Products 15

IND/CTA Filed Products/Combination Treatment Modalities 15

Preclinical Products/Combination Treatment Modalities 16

Sinovac Biotech Ltd. - Drug Profiles 17

(measles + mumps + rubella) vaccine - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

chickenpox vaccine - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

coxsackievirus [serotype A16] vaccine - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

diphtheria + pertussis(acellular) + tetanus vaccine - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

haemophilus influenzae B vaccine - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

hepatitis A + hepatitis B vaccine - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

hepatitis B vaccine - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

influenza [strain A/H7N9] vaccine - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

polio vaccine - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

rabies vaccine - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

rotavirus vaccine - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

Sinovac Biotech Ltd. - Pipeline Analysis 28

Sinovac Biotech Ltd. - Pipeline Products by Molecule Type 28

Sinovac Biotech Ltd. - Dormant Projects 29

Sinovac Biotech Ltd. - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Tables

List of Tables

Sinovac Biotech Ltd., Key Facts 5

Sinovac Biotech Ltd. – Pipeline by Indication, 2016 8

Sinovac Biotech Ltd. – Pipeline by Stage of Development, 2016 9

Sinovac Biotech Ltd. – Monotherapy Products in Pipeline, 2016 10

Sinovac Biotech Ltd. – Combination Treatment Modalities in Pipeline, 2016 11

Sinovac Biotech Ltd. – Partnered Products in Pipeline, 2016 12

Sinovac Biotech Ltd. – Partnered Products/ Combination Treatment Modalities, 2016 13

Sinovac Biotech Ltd. – Phase I, 2016 14

Sinovac Biotech Ltd. – IND/CTA Filed, 2016 15

Sinovac Biotech Ltd. – Preclinical, 2016 16

Sinovac Biotech Ltd. – Pipeline by Molecule Type, 2016 28

Sinovac Biotech Ltd. – Dormant Developmental Projects,2016 29

Sinovac Biotech Ltd., Subsidiaries 30

List of Figures

List of Figures

Sinovac Biotech Ltd. – Pipeline by Top 10 Indication, 2016 7

Sinovac Biotech Ltd. – Pipeline by Stage of Development, 2016 9

Sinovac Biotech Ltd. – Monotherapy Products in Pipeline, 2016 10

Sinovac Biotech Ltd. – Combination Treatment Modalities in Pipeline, 2016 11

Sinovac Biotech Ltd. – Partnered Products in Pipeline, 2016 12

Sinovac Biotech Ltd. – Pipeline by Molecule Type, 2016 28

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports